MedTrace Logo

Platelet Aggregation and Adenosine Levels Among Patients Taking Ticagrelor or Prasugrel

NCT05247385 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 87

Last updated 2022-02-18

No results posted yet for this study

Summary

Prospective, single-center, double blind, double dummy, randomized trial. Platelet function tests and adenosine levels were assessed at baseline and 15 days after taking Ticagrelor with Prasugrel placebo or Prasugrel with Ticagrelor placebo in stable patients with coronary artery disease

Conditions

Interventions

DRUG

Prasugrel

Compared platelet inhibition and adenosine levels at baseline and after 15 days

DRUG

Ticagrelor

Compared platelet inhibition and adenosine levels at baseline and after 15 days

Sponsors & Collaborators

  • University of Sao Paulo

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-20
Primary Completion
2021-02-26
Completion
2021-12-20

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05247385 on ClinicalTrials.gov